Annual Operating Profit
-$190.65 M
-$58.51 M-44.28%
31 December 2023
Summary:
Cullinan Oncology annual operaing income is currently -$190.65 million, with the most recent change of -$58.51 million (-44.28%) on 31 December 2023. During the last 3 years, it has fallen by -$130.31 million (-215.98%). CGEM annual operating profit is now -522226.03% below its all-time high of -$36.50 thousand, reached on 01 December 2008.CGEM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$48.85 M
+$1.17 M+2.34%
30 September 2024
Summary:
Cullinan Oncology quarterly operating income is currently -$48.85 million, with the most recent change of +$1.17 million (+2.34%) on 30 September 2024. Over the past year, it has dropped by -$4.05 million (-9.04%). CGEM quarterly operating profit is now -3660.86% below its all-time high of $1.37 million, reached on 31 March 2021.CGEM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$187.36 M
-$4.05 M-2.21%
30 September 2024
Summary:
Cullinan Oncology TTM operating income is currently -$187.36 million, with the most recent change of -$4.05 million (-2.21%) on 30 September 2024. Over the past year, it has dropped by -$9.58 million (-5.39%). CGEM TTM operating profit is now -7138.96% below its all-time high of $2.66 million, reached on 01 March 2019.CGEM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGEM Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.3% | -9.0% | -5.4% |
| 3 y3 years | -216.0% | -165.9% | -198.4% |
| 5 y5 years | -1207.1% | -10000.0% | -8836.6% |
CGEM Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -216.0% | at low | -165.9% | +22.1% | -198.4% | +1.7% |
| 5 y | 5 years | -1207.1% | at low | -3660.9% | +22.1% | -8836.6% | +1.7% |
| alltime | all time | <-9999.0% | at low | -3660.9% | +22.1% | -7139.0% | +1.7% |
Cullinan Oncology Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$48.85 M(-2.3%) | -$187.36 M(+2.2%) |
| June 2024 | - | -$50.03 M(+16.4%) | -$183.30 M(+7.3%) |
| Mar 2024 | - | -$42.99 M(-5.5%) | -$170.88 M(-10.4%) |
| Dec 2023 | -$190.65 M(+44.3%) | -$45.48 M(+1.5%) | -$190.65 M(+7.2%) |
| Sept 2023 | - | -$44.80 M(+19.1%) | -$177.77 M(+9.2%) |
| June 2023 | - | -$37.60 M(-40.1%) | -$162.74 M(+0.3%) |
| Mar 2023 | - | -$62.76 M(+92.5%) | -$162.24 M(+22.8%) |
| Dec 2022 | -$132.14 M(+94.5%) | -$32.61 M(+9.5%) | -$132.14 M(-1.3%) |
| Sept 2022 | - | -$29.77 M(-19.8%) | -$133.88 M(+9.3%) |
| June 2022 | - | -$37.11 M(+13.6%) | -$122.48 M(+20.1%) |
| Mar 2022 | - | -$32.66 M(-4.9%) | -$101.98 M(+50.1%) |
| Dec 2021 | -$67.95 M(+12.6%) | -$34.35 M(+86.9%) | -$67.95 M(+8.2%) |
| Sept 2021 | - | -$18.38 M(+10.7%) | -$62.78 M(+12.3%) |
| June 2021 | - | -$16.60 M(-1310.2%) | -$55.90 M(+4.6%) |
| Mar 2021 | - | $1.37 M(-104.7%) | -$53.42 M(-11.5%) |
| Dec 2020 | -$60.34 M(+170.9%) | -$29.17 M(+153.7%) | -$60.34 M(+66.9%) |
| Sept 2020 | - | -$11.50 M(-18.6%) | -$36.14 M(+48.7%) |
| June 2020 | - | -$14.12 M(+154.9%) | -$24.30 M(+138.3%) |
| Mar 2020 | - | -$5.54 M(+11.3%) | -$10.20 M(+185.7%) |
| Dec 2019 | -$22.27 M | -$4.98 M(-1574.4%) | -$3.57 M(-266.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $337.70 K(-2237.3%) | $2.14 M(+10.7%) |
| June 2019 | - | -$15.80 K(-101.5%) | $1.94 M(-27.2%) |
| Mar 2019 | - | $1.09 M(+47.8%) | $2.66 M(+17.8%) |
| Dec 2018 | -$14.59 M(+6138.7%) | - | - |
| Dec 2018 | - | $735.60 K(+465.0%) | $2.26 M(+91.8%) |
| Sept 2018 | - | $130.20 K(-81.6%) | $1.18 M(-28.3%) |
| June 2018 | - | $708.90 K(+3.5%) | $1.64 M(+44.1%) |
| Mar 2018 | - | $684.80 K(-297.9%) | $1.14 M(+150.7%) |
| Dec 2017 | - | -$346.10 K(-158.3%) | $454.50 K(-43.2%) |
| Sept 2017 | - | $594.10 K(+187.7%) | $800.60 K(+287.7%) |
| June 2017 | - | $206.50 K | $206.50 K |
| Dec 2016 | -$233.80 K(+225.6%) | - | - |
| Dec 2015 | -$71.80 K(-38.2%) | - | - |
| Dec 2014 | -$116.20 K(-82.8%) | - | - |
| Dec 2013 | -$676.80 K(+285.6%) | - | - |
| Dec 2012 | -$175.50 K(+9.2%) | - | - |
| Dec 2011 | -$160.70 K(-80.1%) | - | - |
| Dec 2010 | -$806.50 K(+106.5%) | - | - |
| Dec 2009 | -$390.50 K(+969.9%) | - | - |
| Dec 2008 | -$36.50 K | - | - |
FAQ
- What is Cullinan Oncology annual operaing income?
- What is the all time high annual operating profit for Cullinan Oncology?
- What is Cullinan Oncology annual operating profit year-on-year change?
- What is Cullinan Oncology quarterly operating income?
- What is the all time high quarterly operating profit for Cullinan Oncology?
- What is Cullinan Oncology quarterly operating profit year-on-year change?
- What is Cullinan Oncology TTM operating income?
- What is the all time high TTM operating profit for Cullinan Oncology?
- What is Cullinan Oncology TTM operating profit year-on-year change?
What is Cullinan Oncology annual operaing income?
The current annual operating profit of CGEM is -$190.65 M
What is the all time high annual operating profit for Cullinan Oncology?
Cullinan Oncology all-time high annual operaing income is -$36.50 K
What is Cullinan Oncology annual operating profit year-on-year change?
Over the past year, CGEM annual operaing income has changed by -$58.51 M (-44.28%)
What is Cullinan Oncology quarterly operating income?
The current quarterly operating profit of CGEM is -$48.85 M
What is the all time high quarterly operating profit for Cullinan Oncology?
Cullinan Oncology all-time high quarterly operating income is $1.37 M
What is Cullinan Oncology quarterly operating profit year-on-year change?
Over the past year, CGEM quarterly operating income has changed by -$4.05 M (-9.04%)
What is Cullinan Oncology TTM operating income?
The current TTM operating profit of CGEM is -$187.36 M
What is the all time high TTM operating profit for Cullinan Oncology?
Cullinan Oncology all-time high TTM operating income is $2.66 M
What is Cullinan Oncology TTM operating profit year-on-year change?
Over the past year, CGEM TTM operating income has changed by -$9.58 M (-5.39%)